NR3C1 and prostate cancer: The global effect of CpdA and the glucocorticoids on gene expression was compared by DNA array analyses in A549 lung carcinoma and Granta-519 lymphoma cells with endogenous GR; and in prostate cancer LNCaP-GR cells stably expressing exogenous GR.